WinterLight Labs

Vocal biomarkers for use in clinical trials

Toronto, Canada · $5.7M raised

Headquarters
Toronto
Employees
11–50
Business Model
B2B
Total Funding
$5.7M
Last Round
$4.2M Series ANov 2019
Rounds
2

About

WinterLight Labs is a Toronto-based health technology company that developed a proprietary speech-based digital biomarker platform for detecting and monitoring neurological and psychiatric diseases, including Alzheimer's disease and frontotemporal dementia. By analyzing over 500 vocal and linguistic characteristics from short speech samples, its tablet-based Winterlight Assessment achieves diagnostic accuracies between 82% and 100% and has been deployed in over a dozen clinical trials with life science partners. The company was acquired by Cambridge Cognition in January 2023 for £7 million to address a $220 million market for speech-based clinical biomarkers.

Summary

WinterLight Labs is an Artificial Intelligence company based in Toronto, Canada. It has raised $5.7M in total across 2 rounds, most recently a $4.2M Series A round in Nov 2019. Investors include Hikma Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ANov 2019
$4.2M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

WinterLight Labs on Indexed.vc
<a href="https://indexed.vc/companies/winterlight-labs"><img src="https://indexed.vc/api/badge/company/winterlight-labs" alt="WinterLight Labs on Indexed.vc" width="260" height="76" /></a>